The therapeutic effect of ultrasound targeted destruction of schisandrin A contrast microbubbles on liver cancer and its mechanism

1. Szabo TL. Diagnostic ultrasound imaging: inside out. 2nd edition. Academic Press; Elsevier Inc. 2014. doi: 10.1016/C2011-0-07261-7 SzaboTL Diagnostic ultrasound imaging: inside out 2nd edition Academic Press Elsevier Inc 2014 10.1016/C2011-0-07261-7 Open DOISearch in Google Scholar

2. Sennoga CA, Kanbar E, Auboire L, Dujardin PA, Fouan D, Escoffre JM, et al. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring. Expert Opin Drug Deliv 2017; 14: 1031–43. doi: 10.1080/17425247.2017.1266328 SennogaCA KanbarE AuboireL DujardinPA FouanD EscoffreJM Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring Expert Opin Drug Deliv 2017 14 1031 43 10.1080/17425247.2017.1266328 Open DOISearch in Google Scholar

3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71: 209–49. doi: 10.3322/caac.21660 SungH FerlayJ SiegelRL LaversanneM SoerjomataramI JemalA Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2021 71 209 49 10.3322/caac.21660 Open DOISearch in Google Scholar

4. Liu CY, Chen KF, Chen PJ. Treatment of liver cancer. Cold Spring Harb Perspect Med 2015; 5: a021535. doi: 10.1101/cshperspect.a0215 LiuCY ChenKF ChenPJ Treatment of liver cancer Cold Spring Harb Perspect Med 2015 5 a021535 10.1101/cshperspect.a0215 Open DOISearch in Google Scholar

5. Yamashita T, Kaneko S. [Liver Cancer]. [Japanese]. Rinsho Byori 2016; 64: 787–96. PMID: 30695467 YamashitaT KanekoS [Liver Cancer]. [Japanese] Rinsho Byori 2016 64 787 96 30695467 Search in Google Scholar

6. Makovec T. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol 2019; 53: 148–58. doi: 10.2478/raon-2019-0018 MakovecT Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy Radiol Oncol 2019 53 148 58 10.2478/raon-2019-0018 Open DOISearch in Google Scholar

7. Kooiman K, Roovers S, Langeveld SAG, Kleven RT, Dewitte H, O’Reilly MA, et al. Ultrasound-responsive cavitation nuclei for therapy and drug delivery. Ultrasound Med Biol 2020; 46: 1296–325. doi: 10.1016/j.ultrasmedbio.2020.01.002 KooimanK RooversS LangeveldSAG KlevenRT DewitteH O’ReillyMA Ultrasound-responsive cavitation nuclei for therapy and drug delivery Ultrasound Med Biol 2020 46 1296 325 10.1016/j.ultrasmedbio.2020.01.002 Open DOISearch in Google Scholar

8. Liu S, Zhang Y, Liu Y, Wang W, Gao S, Yuan W, et al. Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect. Br J Cancer 2023; 128: 715–25. doi: 10.1038/s41416-022-02076-y LiuS ZhangY LiuY WangW GaoS YuanW Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect Br J Cancer 2023 128 715 25 10.1038/s41416-022-02076-y Open DOISearch in Google Scholar

9. Chen H, Hwang JH. Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. J Ther Ultrasound 2013; 1: 10. doi: 10.1186/2050-5736-1-10 ChenH HwangJH Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors J Ther Ultrasound 2013 1 10 10.1186/2050-5736-1-10 Open DOISearch in Google Scholar

10. Schoen S Jr, Kilinc MS, Lee H, Guo Y, Degertekin FL, Woodworth GF, et al. Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound. Adv Drug Deliv Rev 2022; 180: 114043. doi: 10.1016/j.addr.2021.114043 SchoenSJr KilincMS LeeH GuoY DegertekinFL WoodworthGF Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound Adv Drug Deliv Rev 2022 180 114043 10.1016/j.addr.2021.114043 Open DOISearch in Google Scholar

11. Escoffre JM, Sekkat N, Oujagir E, Bodard S, Mousset C, Presset A, et al. Delivery of anti-cancer drugs using microbubble-assisted ultrasound in digestive oncology: from preclinical to clinical studies. Expert Opin Drug Deliv 2022; 19: 421–33. doi: 10.1080/17425247.2022.2061459 EscoffreJM SekkatN OujagirE BodardS MoussetC PressetA Delivery of anti-cancer drugs using microbubble-assisted ultrasound in digestive oncology: from preclinical to clinical studies Expert Opin Drug Deliv 2022 19 421 33 10.1080/17425247.2022.2061459 Open DOISearch in Google Scholar

12. Fu K, Zhou H, Wang C, Gong L, Ma C, Zhang Y, et al. A review: pharmacology and pharmacokinetics of schisandrin A. Phytother Res 2022; 36: 2375–93. doi: 10.1002/ptr.7456 FuK ZhouH WangC GongL MaC ZhangY A review: pharmacology and pharmacokinetics of schisandrin A Phytother Res 2022 36 2375 93 10.1002/ptr.7456 Open DOISearch in Google Scholar

13. Wang X, Zhou L, Zhang T, Chen H, Song X, Wang F. Effect and mechanism of schizandrin A in the treatment of liver cancer using network pharmacology, molecular docking, and target validation. Nat Prod Commun 2023; 18: 1–12. doi: 10.1177/1934578X231176916 WangX ZhouL ZhangT ChenH SongX WangF Effect and mechanism of schizandrin A in the treatment of liver cancer using network pharmacology, molecular docking, and target validation Nat Prod Commun 2023 18 1 12 10.1177/1934578X231176916 Open DOISearch in Google Scholar

14. Omata D, Munakata L, Kageyama S, Suzuki Y, Maruyama T, Shima T, et al. Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubbles. J Drug Target 2022; 30: 200–7. doi: 10.1080/1061186X.2021.1953510 OmataD MunakataL KageyamaS SuzukiY MaruyamaT ShimaT Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubbles J Drug Target 2022 30 200 7 10.1080/1061186X.2021.1953510 Open DOISearch in Google Scholar

15. Zhang J, Yang J, Zhang H, Hu M, Li J, Zhang X. New Span-PEG-composited Fe3O4-CNT as a multifunctional ultrasound contrast agent for inflammation and thrombotic niduses. RSC Adv 2020; 10: 38592–600. doi: 10.1039/d0ra05401a ZhangJ YangJ ZhangH HuM LiJ ZhangX New Span-PEG-composited Fe3O4-CNT as a multifunctional ultrasound contrast agent for inflammation and thrombotic niduses RSC Adv 2020 10 38592 600 10.1039/d0ra05401a Open DOISearch in Google Scholar

16. Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006; 160: 171–77. doi: 10.1016/j.toxlet.2005.07.001 FotakisG TimbrellJA In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride Toxicol Lett 2006 160 171 77 10.1016/j.toxlet.2005.07.001 Open DOISearch in Google Scholar

17. Liu Y, Jiang J, Liu C, Zhao W, Ma Y, Zheng Z, et al. Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma. Am J Transl Res 2021; 13: 988–1005. PMID: 33841635 LiuY JiangJ LiuC ZhaoW MaY ZhengZ Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma Am J Transl Res 2021 13 988 1005 33841635 Search in Google Scholar

18. Yu B, Sheng D, Tan Q. Determination of schisandrin A and schisandrin B in traditional chinese medicine preparation huganpian tablet by RP-HPLC. Chem Pharm Bull 2019; 67: 713–6. doi: 10.1248/cpb.c18-00968 YuB ShengD TanQ Determination of schisandrin A and schisandrin B in traditional chinese medicine preparation huganpian tablet by RP-HPLC Chem Pharm Bull 2019 67 713 6 10.1248/cpb.c18-00968 Open DOISearch in Google Scholar

19. Auboire L, Sennoga CA, Hyvelin JM, Ossant F, Escoffre JM, Tranquart F, et al. Microbubbles combined with ultrasound therapy in ischemic stroke: a systematic review of in-vivo preclinical studies. PLoS One 2018; 13: e0191788. doi: 10.1371/journal.pone.0191788 AuboireL SennogaCA HyvelinJM OssantF EscoffreJM TranquartF Microbubbles combined with ultrasound therapy in ischemic stroke: a systematic review of in-vivo preclinical studies PLoS One 2018 13 e0191788 10.1371/journal.pone.0191788 Open DOISearch in Google Scholar

20. Lammertink BH, Bos C, Deckers R, Storm G, Moonen CT, Escoffre JM. Sonochemotherapy: from bench to bedside. Front Pharmacol 2015; 6: 138. doi: 10.3389/fphar.2015.00138 LammertinkBH BosC DeckersR StormG MoonenCT EscoffreJM Sonochemotherapy: from bench to bedside Front Pharmacol 2015 6 138 10.3389/fphar.2015.00138 Open DOISearch in Google Scholar

21. Bouakaz A, Versluis M, Borsboom J, de Jong N. Radial modulation of microbubbles for ultrasound contrast imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2007; 54: 2283–90. doi: 10.1109/tuffc.2007.532 BouakazA VersluisM BorsboomJ de JongN Radial modulation of microbubbles for ultrasound contrast imaging IEEE Trans Ultrason Ferroelectr Freq Control 2007 54 2283 90 10.1109/tuffc.2007.532 Open DOISearch in Google Scholar

22. Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, et al. Up-down regulation of HIF-1α in cancer progression. Gene 2021; 798: 145796. doi: 10.1016/j.gene.2021.145796 RashidM ZadehLR BaradaranB MolaviO GhesmatiZ SabzichiM Up-down regulation of HIF-1α in cancer progression Gene 2021 798 145796 10.1016/j.gene.2021.145796 Open DOISearch in Google Scholar

23. Frezzetti D, Gallo M, Maiello MR, D’Alessio A, Esposito C, Chicchinelli N, et al. VEGF as a potential target in lung cancer. Expert Opin Ther Targets 2017; 21: 959–66. doi: 10.1080/14728222.2017.1371137 FrezzettiD GalloM MaielloMR D’AlessioA EspositoC ChicchinelliN VEGF as a potential target in lung cancer Expert Opin Ther Targets 2017 21 959 66 10.1080/14728222.2017.1371137 Open DOISearch in Google Scholar

24. Liu XJ, Zhao HC, Hou SJ, Zhang HJ, Cheng L, Yuan S, et al. Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorg Chem 2023; 133: 106425. doi: 10.1016/j.bioorg.2023.106425 LiuXJ ZhaoHC HouSJ ZhangHJ ChengL YuanS Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy Bioorg Chem 2023 133 106425 10.1016/j.bioorg.2023.106425 Open DOISearch in Google Scholar

25. Kim KW, Lee SJ, Kim JC. TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia. Exp Eye Res 2017; 164: 74–81. doi: 10.1016/j.exer.2017.08.008 KimKW LeeSJ KimJC TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia Exp Eye Res 2017 164 74 81 10.1016/j.exer.2017.08.008 Open DOISearch in Google Scholar

26. Wang W, Dong X, Liu Y, Ni B, Sai N, You L, et al. Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways. Biomed Pharmacother 2020; 131: 110661. doi: 10.1016/j.biopha.2020.110661 WangW DongX LiuY NiB SaiN YouL Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways Biomed Pharmacother 2020 131 110661 10.1016/j.biopha.2020.110661 Open DOISearch in Google Scholar

27. Liu X, Zhou Q, Hart JR, Xu Y, Yang S, Yang D, et al. Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα. Proc Natl Acad Sci U S A 2022; 119: e2215621119. doi: 10.1073/pnas.2215621119 LiuX ZhouQ HartJR XuY YangS YangD Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα Proc Natl Acad Sci U S A 2022 119 e2215621119 10.1073/pnas.2215621119 Open DOISearch in Google Scholar

28. Xiang X, Zhao J, Xu G, Li Y, Zhang W. mTOR and the differentiation of mesenchymal stem cells. Acta Biochim Biophys Sin 2011; 43: 501–10. doi: 10.1093/abbs/gmr041 XiangX ZhaoJ XuG LiY ZhangW mTOR and the differentiation of mesenchymal stem cells Acta Biochim Biophys Sin 2011 43 501 10 10.1093/abbs/gmr041 Open DOISearch in Google Scholar

29. Tian LY, Smit DJ, Jücker M. The Role of PI3K/AKT/mTOR Signaling in hepato-cellular carcinoma metabolism. Int J Mol Sci 2023; 24: 2652. doi: 10.3390/ijms24032652 TianLY SmitDJ JückerM The Role of PI3K/AKT/mTOR Signaling in hepato-cellular carcinoma metabolism Int J Mol Sci 2023 24 2652 10.3390/ijms24032652 Open DOISearch in Google Scholar